ENTRY       D08559                      Drug
NAME        Tamoxifen (INN);
            Tamoxifen (TN);
            Tamoplex (TN)
FORMULA     C26H29NO
EXACT_MASS  371.2249
MOL_WEIGHT  371.5146
CLASS       Antineoplastic
             DG01585  Estrogen receptor antagonist
            Other
             DG01619  Clomifene and tamoxifen derivative
              DG01620  Tamoxifene-type antineoplastic
            Cyp substrate
             DG01892  CYP1A2 substrate
             DG01642  CYP2C9 substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A substrate
REMARK      Same as: C07108
            ATC code: L02BA01
            Chemical group: DG00734
ACTIVITY    Antineoplastic, Estrogen receptor agonist/antagonist
COMMENT     Selective estrogen receptor modulator (SERM)
            Active form of prodrug: Endoxifen [CPD:C16547]
            Indication: Metastatic breast cancer
            Use Tamoxifen to Patients who have factor V leiden mutation or prothrombin mutation is at risk of increase deep venous thrombosis (DVT).
TARGET      NR3A1 (ESR1) [HSA:2099] [KO:K08550];
            NR3A2 (ESR2) [HSA:2100] [KO:K08551]
METABOLISM  Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576], CYP1A2 [HSA:1544], CYP2C9 [HSA:1559]
INTERACTION Genomic biomarker: ESR [HSA:2099 2100], PGR [HSA:5241], F5 [HSA:2153], F2 [HSA:2147]
            Transporter inhibition: ABCC2 [HSA:1244]
STR_MAP     map07043  Antineoplastics - hormones
            map07226  Progesterone, androgen and estrogen receptor agonists/antagonists
OTHER_MAP   map00982  Drug metabolism - cytochrome P450
            map01522  Endocrine resistance
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L02 ENDOCRINE THERAPY
               L02B HORMONE ANTAGONISTS AND RELATED AGENTS
                L02BA Anti-estrogens
                 L02BA01 Tamoxifen
                  D08559  Tamoxifen (INN)
            USP drug classification [BR:br08302]
             Antineoplastics
              Antiestrogens/Modifiers
               Tamoxifen
                D08559  Tamoxifen (INN)
            Target-based classification of drugs [BR:br08310]
             Nuclear receptors
              Estrogen like receptors
               Estrogen receptor
                estrogen receptor 1
                 Tamoxifen
                  D08559  Tamoxifen (INN)
                estrogen receptor 2
                 Tamoxifen
                  D08559  Tamoxifen (INN)
            Cytochrome P450 interactions [BR:br08309]
             CYP substrates
              CYP1A2
               Tamoxifen
                D08559  Tamoxifen (INN)
              CYP2C9
               Tamoxifen
                D08559  Tamoxifen (INN)
              CYP2D6
               Tamoxifen
                D08559  Tamoxifen (INN)
              CYP3A4
               Tamoxifen
                D08559  Tamoxifen (INN)
             Transporter inhibitors
              ABCC2
               Tamoxifen
                D08559  Tamoxifen (INN)
DBLINKS     CAS: 10540-29-1
            PubChem: 96025244
            ChEBI: 41774
            ChEMBL: CHEMBL83
            DrugBank: DB00675
            PDB-CCD: CTX
            LigandBox: D08559
            NIKKAJI: J10.452C
ATOM        28
            1   C8x C    24.7800  -19.3200
            2   C8y C    24.7800  -20.7200
            3   C8x C    23.5900  -21.4200
            4   C8x C    22.3300  -20.7200
            5   C8y C    22.3300  -19.3200
            6   C8x C    23.5900  -18.6200
            7   C8x C    19.8800  -20.7200
            8   C8y C    19.8800  -19.3200
            9   C2c C    21.1400  -18.6200
            10  C8x C    18.6900  -21.4200
            11  C8x C    17.5000  -20.7200
            12  C8x C    17.5000  -19.3200
            13  C8x C    18.6900  -18.6200
            14  C2c C    21.1400  -17.2200
            15  C1b C    19.8800  -16.5200
            16  C8y C    22.3300  -16.5200
            17  O2a O    25.9700  -21.4200
            18  C1b C    27.1600  -20.7200
            19  C1b C    28.3500  -21.4200
            20  C8x C    22.3300  -15.1200
            21  C8x C    23.5200  -14.4200
            22  C8x C    24.7800  -15.1200
            23  C8x C    24.7800  -16.5200
            24  C8x C    23.5200  -17.2200
            25  N1c N    29.5400  -20.7200
            26  C1a C    30.8000  -21.4200
            27  C1a C    29.5400  -19.3200
            28  C1a C    18.6900  -17.2200
BOND        30
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     7   8 1
            8     8   9 1
            9     5   9 1
            10    7  10 2
            11   10  11 1
            12   11  12 2
            13   12  13 1
            14    8  13 2
            15    9  14 2
            16   14  15 1
            17   14  16 1
            18    2  17 1
            19   17  18 1
            20   18  19 1
            21   16  20 2
            22   20  21 1
            23   21  22 2
            24   22  23 1
            25   23  24 2
            26   16  24 1
            27   19  25 1
            28   25  26 1
            29   25  27 1
            30   15  28 1
///
